Words of wisdom. Re: androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology

Affiliations

¹ Department of Urology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9110, USA. Arthur.Sagalowsky@UTSouthwestern.edu

Comment

Arthur L Sagalowsky. Eur Urol. 2010 Oct.

. 2010 Oct;58(4):630.

doi: 10.1016/j.eururo.2010.07.014.

¹ Department of Urology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9110, USA. Arthur.Sagalowsky@UTSouthwestern.edu

No abstract available

Comment on

Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology.
Levine GN, D'Amico AV, Berger P, Clark PE, Eckel RH, Keating NL, Milani RV, Sagalowsky AI, Smith MR, Zakai N; American Heart Association Council on Clinical Cardiology and Council on Epidemiology and Prevention, the American Cancer Society, and the American Urological Association. Levine GN, et al. Circulation. 2010 Feb 16;121(6):833-40. doi: 10.1161/CIRCULATIONAHA.109.192695. Epub 2010 Feb 1. Circulation. 2010. PMID: 20124128 Free PMC article. No abstract available.